Tag:
Alnylam
Latest Headlines
Latest Headlines
Alnylam, Medtronic highlight RNAi drug-device combo data
Alnylam Pharmaceuticals ($ALNY) and Medtronic ( $MDT ), with the support of the nonprofit CHDI Foundation, are evaluating their RNAi drug-device combination to treat Huntington's disease. They point to
Flu vax tool aids strain identification, timing
As manufacturers and researchers toil on alternatives to the tried-and-true but time-consuming technique of egg-based production for the seasonal flu vaccine, University of Pittsburgh researchers are
GSK, Alnylam team to speed vaccine production
Evidence of advances to speed up vaccine manufacturing--a wish-list item for governments around the world wanting to establish national disease-protection programs--appeared on two fronts this week.
Great minds collaborate on new RNAi approach to inflammation
A high profile team of scientists, including MIT's Robert Langer, investigators for Cambridge, MA-based Alnylam, as well as scientists from the Massachusetts General Hospital collaborated on a new
Biotech brings hamsters to manufacturing
Cambridge, MA-based biotech Alnylam says that its genetics expertise in drug development also may be useful in biologics manufacturing. In a company update to investors last week, management
